Evidence map›Paper›PMID 35624710›Full record

ArticleAntioxidants (Basel, Switzerland)2022

NiONP-Induced Oxidative Stress and Mitochondrial Impairment in an In Vitro Pulmonary Vascular Cell Model Mimicking Endothelial Dysfunction.

Ophélie Germande, Thomas Ducret, Jean-Francois Quignard, Juliette Deweirdt, Véronique Freund-Michel, Marie-Hélène Errera, Guillaume Cardouat, Pierre Vacher, Bernard Muller, Patrick Berger and 3 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Ophélie GermandeUniversité de Bordeaux, 146, Rue Léo Saignat, F-33076 Bordeaux, France.
Thomas DucretUniversité de Bordeaux, 146, Rue Léo Saignat, F-33076 Bordeaux, France.
Jean-Francois QuignardUniversité de Bordeaux, 146, Rue Léo Saignat, F-33076 Bordeaux, France.
Juliette DeweirdtANSES, Agence Nationale de Sécurité Sanitaire de L'alimentation de L'environnement et du Travail, Direction de L'Évaluation des Risques, Unité Évaluation des Substances Chimiques, F-94701 Maisons-Alfort, France.ORCID 0000-0002-0275-5058
Véronique Freund-MichelUniversité de Bordeaux, 146, Rue Léo Saignat, F-33076 Bordeaux, France.
Marie-Hélène ErreraDepartment of Ophtalmology, University of Pittsburgh School of Medecine, Pittsburgh, PA 15260, USA.
Guillaume CardouatUniversité de Bordeaux, 146, Rue Léo Saignat, F-33076 Bordeaux, France.ORCID 0000-0002-2990-8907
Pierre VacherInserm U 1045, Centre de Recherche Cardio-Thoracique, Avenue du Haut Lêveque, F-33604 Pessac, France.ORCID 0000-0003-3503-7981
Bernard MullerUniversité de Bordeaux, 146, Rue Léo Saignat, F-33076 Bordeaux, France.
Patrick BergerUniversité de Bordeaux, 146, Rue Léo Saignat, F-33076 Bordeaux, France.
Christelle GuibertInserm U 1045, Centre de Recherche Cardio-Thoracique, Avenue du Haut Lêveque, F-33604 Pessac, France.ORCID 0000-0003-3253-5694
Magalie BaudrimontUniversité de Bordeaux, 146, Rue Léo Saignat, F-33076 Bordeaux, France.ORCID 0000-0001-9901-8435
Isabelle BaudrimontUniversité de Bordeaux, 146, Rue Léo Saignat, F-33076 Bordeaux, France.ORCID 0000-0001-8174-835X
Université de Bordeaux · FRCentre National de la Recherche Scientifique · FRInserm · FRAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail · FRUniversity of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development and use of nanomaterials, especially of nickel oxide nanoparticles (NiONPs), is expected to provide many benefits but also has raised concerns about the potential human health risks. Inhaled NPs are known to exert deleterious cardiovascular side effects, including pulmonary hypertension. Consequently, patients with pulmonary hypertension (PH) could be at increased risk for morbidity. The objective of this study was to compare the toxic effects of NiONPs on human pulmonary artery endothelial cells (HPAEC) under physiological and pathological conditions. The study was conducted with an in vitro model mimicking the endothelial dysfunction observed in PH. HPAEC were cultured under physiological (static and normoxic) or pathological (20% cycle stretch and hypoxia) conditions and exposed to NiONPs (0.5-5 μg/cm

Indexed as

calciumcyclic stretchendothelial dysfunctionhuman pulmonary artery endothelial cellsmitochondria alterationnickel oxide nanoparticlesreactive oxygen species

Identifiers

PMID35624710
PMCPMC9137840
OpenAlexW4224999478

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.